公开(公告)号：NO20062202A

公开(公告)日：2006-07-03

申请号：NO20062202

申请日：2006-05-16

Applicant: SOLVAY PHARM GMBH

Inventor： ZIEGLER DIETER ,  WESKE MICHAEL ,  FISCHER YVAN ,  SYKES DAVID ,  MOLONEY BRIAN ,  MARRISON LESTER ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WITTE KLAUS

IPC: C07D311/68 ,  A61K31/353 ,  C07D407/12

CPC classification number: C07D407/12 ,  C07D311/68

公开(公告)号：CA2542813C

公开(公告)日：2011-08-30

申请号：CA2542813

申请日：2004-10-14

Applicant: SOLVAY PHARM GMBH

Inventor： SYKES DAVID ,  MOLONEY BRIAN ,  MARRISON LESTER ,  ZIEGLER DIETER ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WESKE MICHAEL ,  WITTE KLAUS ,  FISCHER YVAN

IPC: C07D311/70 ,  A61K31/353 ,  A61P9/00 ,  A61P37/00 ,  C07D311/68 ,  C07D407/12

Abstract: Compounds of the general formula I, (see formula I) wherein R1, R2, R3, R4, R5 and R6 have the meanings given in the description, and also a process for the preparation of these compounds and intermediate products of this process are described. Furthermore, medicaments containing the compounds of Formula I are specified.

公开(公告)号：SI1678130T1

公开(公告)日：2008-12-31

申请号：SI200430848

申请日：2004-10-14

Applicant: SOLVAY PHARM GMBH

Inventor： SYKES DAVID ,  MOLONEY BRIAN ,  MARRISON LESTER ,  ZIEGLER DIETER ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WESKE MICHAEL ,  WITTE KLAUS ,  FISCHER YVAN

IPC: C07D201/00 ,  A61K31/353 ,  C07D311/68 ,  C07D407/12

公开(公告)号：AU2006234295A1

公开(公告)日：2006-10-19

申请号：AU2006234295

申请日：2006-04-11

Applicant: SOLVAY PHARM GMBH

Inventor： WESKE MICHAEL ,  MOLONEY BRIAN ,  FISCHER YVAN ,  MLINARIC MICHAEL ,  WITTE KLAUS ,  ZIEGLER DIETER ,  MARRISON LESTER ,  BRUECKNER REINHARD ,  BOECKER CHRISTIANE

IPC: C07D311/68 ,  A61K31/353 ,  A61K31/4025 ,  A61K31/453 ,  A61K31/497 ,  A61K31/5355 ,  A61P9/00 ,  C07D405/12 ,  C07D413/12

Abstract: Cardiovascular active compounds of the general formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and n have the meanings given in the description, and also a process for the preparation of these compounds and intermediate products of this process are described. Furthermore, pharmaceutical compositions comprising the compounds of Formula (I) are specified.

公开(公告)号：DE112004001659D2

公开(公告)日：2006-08-10

申请号：DE112004001659

申请日：2004-10-14

Applicant: SOLVAY PHARM GMBH

Inventor： SYKES DAVID ,  MOLONEY BRIAN ,  MARRISON LESTER ,  ZIEGLER DIETER ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WESKE MICHAEL ,  WITTE KLAUS ,  FISCHER YVAN

IPC: C07D311/68 ,  A61K31/352 ,  A61K31/353 ,  A61P9/00 ,  A61P29/00 ,  A61P37/02 ,  C07D407/12

Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.

公开(公告)号：DE10348298A1

公开(公告)日：2005-05-19

申请号：DE10348298

申请日：2003-10-17

Applicant: SOLVAY PHARM GMBH

Inventor： SYKES DAVID ,  MOLONEY BRIAN ,  MARRISON LESTER ,  ZIEGLER DIETER ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WESKE MICHAEL ,  WITTE KLAUS ,  FISCHER YVAN

IPC: A61K31/353 ,  C07D311/68 ,  C07D407/12 ,  A61K31/352

Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.

公开(公告)号：AU2004281195A2

公开(公告)日：2005-04-28

申请号：AU2004281195

申请日：2004-10-14

Applicant: SOLVAY PHARM GMBH

Inventor： MOLONEY BRIAN ,  WESKE MICHAEL ,  SYKES DAVID ,  FISCHER YVAN ,  MLINARIC MICHAEL ,  BOECKER CHRISTIANE ,  BRUECKNER REINHARD ,  WITTE KLAUS ,  MARRISON LESTER ,  ZIEGLER DIETER

IPC: A61K31/353 ,  C07D311/68 ,  C07D407/12

Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.